Landos Biopharma, Inc. Quarterly Earnings Per Share, Basic in USD/shares from Q2 2020 to Q1 2024

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Landos Biopharma, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from Q2 2020 to Q1 2024.
  • Landos Biopharma, Inc. Earnings Per Share, Basic for the quarter ending March 31, 2024 was -1.43 USD/shares, a 53.8% decline year-over-year.
  • Landos Biopharma, Inc. Earnings Per Share, Basic for the twelve months ending March 31, 2024 was -4 USD/shares, a 61.2% increase year-over-year.
  • Landos Biopharma, Inc. annual Earnings Per Share, Basic for 2023 was -3.5 USD/shares, a 64.1% increase from 2022.
  • Landos Biopharma, Inc. annual Earnings Per Share, Basic for 2022 was -9.76 USD/shares, a 857% decline from 2021.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$4 -$1 $1 -53.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$4 -$1 +$3.63 +78.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-21
Q3 2023 -$7 -$1 +$1.02 +52% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 -$8 -$1 +$2.17 +77.5% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-09
Q1 2023 -$10 -$1 -$1 -151% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$10 -$5 Oct 1, 2022 Dec 31, 2022 10-K 2024-03-21
Q3 2022 -$2 -$2 -513% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$3 -$3 -2433% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $0 Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q3 2021 $0 Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $0.12 +$0.52 Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q2 2020 $0 Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.